Summary
- Profile Type
- Business request
- POD Reference
- BRGB20241008016
- Term of Validity
- 8 October 2024 - 8 October 2025
- Company's Country
- United Kingdom
- Type of partnership
- Outsourcing agreement
- Targeted Countries
- Belgium
- Czechia
- Finland
- Estonia
- Austria
- Denmark
- Croatia
- Cyprus
- Bulgaria
- Italy
- Hungary
- Latvia
- Malta
- Netherlands
- France
- Greece
- Lithuania
- Ireland
- Germany
- Luxembourg
- Sweden
- Slovenia
- Portugal
- Spain
- Poland
- Romania
- Slovakia
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- A UK based SME have developed an unlicensed injectable therapeutic for use in cardiac care and are now seeking an outsourcing agreement with a contract manufacturing organisation with expertise in sterile injectable drug manufacturing, ideally with experience in unlicensed UK specials.
- Full Description
-
A UK based Medtech SME have developed an unlicensed injectable therapeutic for use in cardiac care; the product is designed to enhance cardiac surgery outcomes by offering superior myocardial protection. It addresses the unmet need for a ready-to-use solution, eliminating the complexities and risks associated with current in situ preparation methods. The product is currently at technology readiness level 6 and the SME is now seeking an outsourcing agreement with a contract manufacturing organisation with expertise in sterile injectable drug manufacturing.
The partner will be expected to support the SME by taking their order and making the formulation according to their specifications. The desired partner will batch manufacture the units and package them according to certifications outlined by the SME. The partner will also have the ability to support the SME in scaling their production following on from increased demand and will adhere to Good Manufacturing Practice (GMP) standards and comply with all relevant regulatory requirements for pharmaceutical manufacturing, both in the UK and potentially in international markets.
The SME is seeking a long-term partnership with a contract manufacturing organisation that has shared vision of improving patient outcomes and transforming cardiac surgery through innovative solutions. - Stage of Development
- Under development
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR description
-
• Contract Manufacturing Organisation with expertise in sterile injectable drug manufacturing, ideally with experience in unlicensed UK specials and cardiac care therapeutics.
• Adherence to Good Manufacturing Practice (GMP) standards and relevant regulatory requirements for unlicensed specials.
Partner Sought
- Expected Role of a Partner
- The desired partner is a contract manufacturing organisation with expertise in sterile injectable drug manufacturing, ideally with experience in unlicensed UK specials. The partner will be expected to support the SME by taking their order and making the formulation according to their specifications.
- Type and Size of Partner
- SME <=10
- SME 11-49
- SME 50 - 249
- R&D Institution
- Big company
- Type of partnership
- Outsourcing agreement
Dissemination
- Market keywords
- 05007007 - Other medical/health related (not elsewhere classified)
- Targeted countries
- Belgium
- Czechia
- Finland
- Estonia
- Austria
- Denmark
- Croatia
- Cyprus
- Bulgaria
- Italy
- Hungary
- Latvia
- Malta
- Netherlands
- France
- Greece
- Lithuania
- Ireland
- Germany
- Luxembourg
- Sweden
- Slovenia
- Portugal
- Spain
- Poland
- Romania
- Slovakia